Investegate |NOVARTIS AG CHF0.50(REGD) Announcements | NOVAR

Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis continues to grow with further core margin expansion and achieves important innovation milestones

Related Keywords

China , New Zealand , Switzerland , Germany , Australia , Japan , United States , Canada , France , America , French , German , Swiss , Johnd Young , Charlesl Sawyers , Bridgette Heller , Elizabeth Doherty , Patrice Bula , Nancyc Andrews , Simon Moroney , Gleevec Glivec , Daniel Hochstrasser , Promacta Revolade , Afinitor Votubia , Joerg Reinhardt , Frans Van Houten , Moody Investors Service , Pfizer Executive Leadership Team , Novartis Group , Arvinas Inc , Diovan Group , Compensation Committee , Society Integrated , Swiss Exchange , Novartis , Imbria Pharmaceuticals , Exforge Group , Exchange Commission , Boards Of Johnson Controls International , Galvus Group , Committee Of Novartis , Vas Narasimhan , Innovative Medicines , Condensed Financial , Emerging Growth Markets , Western Europe , Malaria Venture , Investors Service , Novartis Board , Annual General Meeting , General Meeting , Executive Leadership Team , Johnson Controls International , Board Chair , Ton Buechner , Ana De Pro Gonzalo , Executive Committee , Condensed Financial Report , Society Integrated Report , Investegate Announcements , Investegate Company Announcements , Ovartis Ag Chf0 50 Regd , Lobenewswire , Lobenewswire And Globenewswire , Nw ,